Bitget App
Trade smarter
US-listed company Sonnet BioTherapeutics postpones merger vote to December 2
Show original
Foresight News reported that the US-listed company Sonnet BioTherapeutics has postponed its merger vote to December 2. Previously, it was reported that Sonnet BioTherapeutics would merge with Rorschach I LLC to form Hyperliquid Strategies and advance the HYPE reserve strategy.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
New Hampshire launches the first bitcoin-backed municipal bond in the United States
Chaincatcher•2025/11/19 00:29
US OCC: Banks Can Hold Certain Cryptocurrencies to Pay Gas Fees
金色财经•2025/11/18 21:31
Nasdaq-listed company Onfolio raises $300 million to establish a digital asset treasury
ForesightNews•2025/11/18 21:22
